Lu AE58054 Hydrochloride ntin) 3-bis(hexadecanoyloxy)propoxy]({2-[(2S)-2-[(4R)-4-carbamoyl-4-[(2S)-2-[(2R)-2-{[(2R

3-bis(hexadecanoyloxy)propoxy]({2-[(2S)-2-[(4R)-4-carbamoyl-4-[(2S)-2-[(2R)-2-{[(2R

Effect of an ectokinase inhibitor

1594094-64-0

Smiles: CC1(C)[C@H]2[C@@H]3C=C(C[C@@]4(O)[C@@H](C=C(C)C4=O)[C@@]3(O)[C@H](C)[C@@H](OC(=O)CCCCCCCCCCCCC)[C@@]12OC(C)=O)CO

Lu AE58054 Hydrochloride ntin) 3-bis(hexadecanoyloxy)propoxy]({2-[(2S)-2-[(4R)-4-carbamoyl-4-[(2S)-2-[(2R)-2-{[(2RIdalopirdine, also known as Lu AE58054 or Iladopirdine, is a potent and selective 5 HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia. It is in phase III clinical trials. Lu AE58054 displayed high affinity to the human 5 HT(6) receptor (5 HT(6)R) with a Ki of 0. 83 nm. Lu AE58054 demonstrated >50 fold selectivity for more than